More evidence of declining incidence of amyloidosis associated with inflammatory rheumatic diseases

References

• Filipowicz-Sosnowska AM, Rostopowicz-Denisiewicz K, Rosenthal CJ, Baum J. The amyloidosis of juvenile rheumatoid arthritis – comparative studies in Polish and American children. I. Levels of serum SAA protein. Arthritis Rheum 1978;21:699–703.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, Matsumoto T, Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol 1996;35:44–9.
   PubMedGoogle Scholar
• Kvalvik AG. Mortality in rheumatoid arthritis. Rheumatol Eur 1996;25:9–14.
   Google Scholar
• Wiland P, Wojtala R, Goodacre J, Szechinski J. The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis. Clin Rheumatol 2004;23:193–8.
   PubMedGoogle Scholar
• Myllykangas-Luosujarvi R, Aho K, Kautiainen H, Isomaki H. Shortening of life span and causes of excess mortality in a population based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol 1995;13:149–53.
   PubMed Web of Science ®Google Scholar
• Myllykangas-Luosujarvi R, Aho K, Lehtinen K, Kautiainen H, Hakala M. Increased incidence of alcohol-related deaths from accidents and violence in subjects with ankylosing spondylitis. Br J Rheumatol 1998;37:688–90.
   PubMedGoogle Scholar
• Savolainen HA, Isomaki HA. Decrease in the number of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis. J Rheumatol 1993;20:1201–3.
   PubMed Web of Science ®Google Scholar
• Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993;52:174–6.
   PubMed Web of Science ®Google Scholar
• Hazenberg BPC, van Rijswijk MH. Where has secondary amyloidosis gone? Ann Rheum Dis 2000;59:577–9.
   PubMed Web of Science ®Google Scholar
• Marsik C, Endler G, Gulesserian T, Wagner OF, Sunder-Plassmann G. Classification of chronic kidney disease by estimated glomerular filtration rate. Eur J Clin Invest 2008;38:253–9.
   PubMed Web of Science ®Google Scholar
• Klemi PJ, Sorsa S, Happonen RP. Fine-needle aspiration biopsy from subcutaneous fat. An easy way to diagnose secondary amyloidosis. Scand J Rheumatol 1987;16:429–31.
   PubMed Web of Science ®Google Scholar
• Dhillon V, Woo P, Isenberg D. Amyloidosis in the rheumatic diseases. Ann Rheum Dis 1989;48:696–701.
   PubMed Web of Science ®Google Scholar
• Laiho K, Tiitinen S, Kaarela K, Helin H, Isomäki H. Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland. Clin Rheumatol 1999;18:122–3.
   PubMed Web of Science ®Google Scholar
• Kaipiainen-Seppanen O, Myllykangas-Luosujarvi R, Lampainen E, Ikaheimo R. Intensive treatment of rheumatoid arthritis reduces need for dialysis due to secondary amyloidosis. Scand J Rheumatol 2000;29:232–5.
   PubMedGoogle Scholar
• Immonen K, Savolainen A, Kautiainen H, Hakala M. Why can we no longer find juvenile idiopathic arthritis-associated amyloidosis in childhood or in adolescence in Finland? Scand J Rheumatol 2007;36:402–3.
   PubMed Web of Science ®Google Scholar
• Finnish Registry for Kidney Diseases. Available from: www.musili.fi/fin/munuaistautirekisteri/finnish_registry_for_kidney_diseases/
   Google Scholar
• Finne P, Reunanen A, Stenman S, Groop P-H, Gronhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. J Am Med Assoc 2005;14:1782–7.
   Google Scholar
• Hakala M, Pöllänen R, Nieminen P. The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population-based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement. J Rheumatol 1993;20:1674–8.
   PubMed Web of Science ®Google Scholar
• Husby G. Amyloidosis in ankylosing spondylitis. Scand J Rheumatol 1980;32(Suppl):67–70.
   Google Scholar
• Hazenberg BPC, Limburg PC, Bijzet J, van Rijwijk MH. Factors influencing onset of amyloidosis and final outcome in patients with rheumatoid arthritis. In: Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle TJ, Young ID, editors. Amyloid and amyloidosis 1993. New York: Parthenon Publishing, 1994:700–2.
   Google Scholar
• Immonen K, Finne P, Hakala M, Kautiainen H, Pettersson T, Gronhagen-Riska C. No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases – data from the Finnish national registry for kidney diseases. J Rheumatol 2008;35:1334–8.
   PubMed Web of Science ®Google Scholar
• Klaukka T, Kaarela K. Methotrexate is the leading DMARD in Finland. Ann Rheum Dis 2003;62:494–6.
   PubMedGoogle Scholar
• Falck HM, Maury CPJ, Teppo A-M, Wegelius O. Correlation of persistently high serum amyloid A and C-reactive protein concentrations with rapid progression of secondary amyloidosis. Br Med J 1983;286:1391–3.
   PubMed Web of Science ®Google Scholar
• Tiitinen S, Kaarela K, Helin H, Kautiainen H, Isomaki H. Amyloidosis – incidence and early risk factors in patients with rheumatoid arthritis. Scand J Rheumatol 1993;22:158–61.
   PubMed Web of Science ®Google Scholar
• Sihvonen S, Korpela M, Mustonen J, Laippala P, Pasternack A. Renal disease as a predictor of increased mortality among patients with rheumatoid arthritis. Nephron Clin Pract 2004;96:107–14.
   PubMedGoogle Scholar
• Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303–7.
   PubMed Web of Science ®Google Scholar
• Peters MJ, van der Horst-Pruinsma IE, Dijkmans BA, Nurmohamed MT. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004;34:585–92.
   PubMed Web of Science ®Google Scholar
• Gertz MA. Secondary systemic amyloidosis. Response and survival in 64 patients. Medicine 1991;70:246–56.
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Goodman HJB, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Natural history and outcome in systemic amyloidosis. N Engl J Med 2007;356:2361–71.
   PubMed Web of Science ®Google Scholar